Detection of Polyglutamine Protein Oligomers in Cells by Fluorescence Correlation Spectroscopy

Yasuo Takahashi, Yuma Okamoto, H. Akiko Popiel, Nobuhiro Fujikake, Tatsushi Toda, Masataka Kinjo, Yoshitaka Nagai

Journal of Biological Chemistry · 2007 · 97 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

Abnormal aggregation of misfolded proteins and their deposition as inclusion bodies in the brain have been implicated as a common molecular pathogenesis of neurodegenerative diseases including Alzheimer, Parkinson, and the polyglutamine (poly(Q)) diseases, which are collectively called the conformational diseases. The poly(Q) diseases, including Huntington disease and various types of spinocerebellar ataxia, are caused by abnormal expansions of the poly(Q) stretch within disease-causing proteins, which triggers the disease-causing proteins to aggregate into insoluble β-sheet-rich amyloid fibrils. Although oligomeric structures formed in vitro are believed to be more toxic than mature amyloid fibrils in these diseases, the existence of oligomers in vivo has remained controversial. To explore oligomer formation in cells, we employed fluorescence correlation spectroscopy (FCS), which is a highly sensitive technique for investigating the dynamics of fluorescent molecules in solution. Here we demonstrate direct evidence for oligomer formation of poly(Q)-green fluorescent protein (GFP) fusion proteins expressed in cultured cells, by showing a time-dependent increase in their diffusion time and particle size by FCS. We show that the poly(Q)-binding peptide QBP1 inhibits poly(Q)-GFP oligomer formation, whereas Congo red only inhibits the growth of oligomers, but not the initial formation of the poly(Q)-GFP oligomers, suggesting that FCS is capable of identifying poly(Q) oligomer inhibitors. We therefore conclude that FCS is a useful technique to monitor the oligomerization of disease-causing proteins in cells as well as its inhibition in the conformational diseases. Abnormal aggregation of misfolded proteins and their deposition as inclusion bodies in the brain have been implicated as a common molecular pathogenesis of neurodegenerative diseases including Alzheimer, Parkinson, and the polyglutamine (poly(Q)) diseases, which are collectively called the conformational diseases. The poly(Q) diseases, including Huntington disease and various types of spinocerebellar ataxia, are caused by abnormal expansions of the poly(Q) stretch within disease-causing proteins, which triggers the disease-causing proteins to aggregate into insoluble β-sheet-rich amyloid fibrils. Although oligomeric structures formed in vitro are believed to be more toxic than mature amyloid fibrils in these diseases, the existence of oligomers in vivo has remained controversial. To explore oligomer formation in cells, we employed fluorescence correlation spectroscopy (FCS), which is a highly sensitive technique for investigating the dynamics of fluorescent molecules in solution. Here we demonstrate direct evidence for oligomer formation of poly(Q)-green fluorescent protein (GFP) fusion proteins expressed in cultured cells, by showing a time-dependent increase in their diffusion time and particle size by FCS. We show that the poly(Q)-binding peptide QBP1 inhibits poly(Q)-GFP oligomer formation, whereas Congo red only inhibits the growth of oligomers, but not the initial formation of the poly(Q)-GFP oligomers, suggesting that FCS is capable of identifying poly(Q) oligomer inhibitors. We therefore conclude that FCS is a useful technique to monitor the oligomerization of disease-causing proteins in cells as well as its inhibition in the conformational diseases. Abnormal aggregation and deposition of misfolded proteins in the brain have been implicated as a common molecular pathogenesis of neurodegenerative diseases including Alzheimer disease, Parkinson disease, and the polyglutamine (poly(Q)) 2The abbreviations used are: poly(Q), polyglutamine; FCS, fluorescence correlation spectroscopy; GFP, green fluorescent protein; YFP, yellow fluorescent protein; CFP, cyan fluorescent protein; FRET, fluorescence resonance energy transfer; CPP, counts per particle; F1, fast diffusion component fractions; F2, slow diffusion component fractions; DT1, fast diffusion times; DT2, slow diffusion times; QBP1, poly(Q)-binding peptide 1; Aβ, amyloid β-protein. diseases, which are collectively called the conformational diseases (1Taylor J.P. Hardy J. Fischbeck K.H. Science. 2002; 296: 1991-1995Crossref PubMed Scopus (1023) Google Scholar, 2Ross C.A. Poirier M.A. Nat. Rev. Mol. Cell Biol. 2005; 6: 891-898Crossref PubMed Scopus (515) Google Scholar, 3Carrell R.W. Lomas D.A. Lancet. 1997; 350: 134-138Abstract Full Text Full Text PDF PubMed Scopus (820) Google Scholar). The poly(Q) diseases are a group of at least nine inherited neurodegenerative diseases including Huntington disease and various types of spinocerebellar ataxia, which are caused by abnormal expansions of the poly(Q) stretch to above 40 glutamines within each unrelated disease-causing protein (4Gusella J.F. MacDonald M.E. Nat. Rev. Neurosci. 2000; 1: 109-115Crossref PubMed Scopus (325) Google Scholar, 5Zoghbi H.Y. Orr H.T. Annu. Rev. Neurosci. 2000; 23: 217-247Crossref PubMed Scopus (1109) Google Scholar). In the pathogenesis of the poly(Q) diseases, expansions of the poly(Q) stretch in disease-causing proteins are believed to cause alterations in the protein conformation, resulting in assembly of the proteins into insoluble β-sheet-rich amyloid-like fibrillar aggregates, and eventually their deposition as inclusion bodies inside affected neurons. However, Finkbeiner and colleagues (6Arrasate M. Mitra S. Schweitzer E.S. Segal M.R. Finkbeiner S. Nature. 2004; 431: 805-810Crossref PubMed Scopus (1627) Google Scholar) demonstrated that neuronal cells with poly(Q) protein inclusions have a decreased risk of death, suggesting that the diffuse poly(Q) protein rather than inclusion bodies causes cytotoxicity. Inclusion bodies, which are large intracellular deposits of aggregated proteins, are believed to be formed as a cytoprotective response against the overproduction of misfolded/aggregated proteins (7Kopito R.R. Trends Cell Biol. 2000; 10: 524-530Abstract Full Text Full Text PDF PubMed Scopus (1614) Google Scholar), whereas oligomers/aggregates are formed by the intrinsic property of misfolded proteins to misassemble. In addition, recent accumulating evidence strongly implies that soluble oligomers are more toxic than mature amyloid fibrils in the conformational diseases in general (8Haass C. Selkoe D.J. Nat. Rev. Mol. Cell Biol. 2007; 8: 101-112Crossref PubMed Scopus (3917) Google Scholar, 9Caughey B. Lansbury P.T. Annu. Rev. Neurosci. 2003; 26: 267-298Crossref PubMed Scopus (1458) Google Scholar, 10Stefani M. Dobson C.M. J. Mol. Med. 2003; 81: 678-699Crossref PubMed Scopus (1356) Google Scholar, 11Klein W.L. Stine Jr., W.B. Teplow D.B. Neurobiol. Aging. 2004; 25: 569-580Crossref PubMed Scopus (425) Google Scholar). However, importantly, there has been little evidence on oligomer formation of the amyloidogenic proteins in vivo so far, although their oligomer formation in vitro has been well characterized. In this study, we employed fluorescence correlation spectroscopy (FCS) to explore oligomerization of the poly(Q) proteins in cells. FCS is known to be a powerful tool for investigating the dynamics of fluorescent probes and molecules in homogeneous solution at single molecule sensitivity, which cannot be analyzed by conventional microscopy (12Eigen M. Rigler R. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 5740-5747Crossref PubMed Scopus (910) Google Scholar, 13Elson E.L. Traffic. 2001; 2: 789-796Crossref PubMed Scopus (105) Google Scholar). Several dynamic properties of the fluorophore, such as the number, diffusion time, and size of the oligomerizing molecules can be obtained (14Terada S. Kinjo M. Hirokawa N. Cell. 2000; 103: 141-155Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar, 15Jankevics H. Prummer M. Izewska P. Pick H. Leufgen K. Vogel H. Biochemistry. 2005; 44: 11676-11683Crossref PubMed Scopus (33) Google Scholar, 16Hirose M. Tohda H. Giga-Hama Y. Tsushima R. Zako T. Iizuka R. Pack C. Kinjo M. Ishii N. Yohda M. J. Biol. Chem. 2005; 280: Full Text Full Text PDF PubMed Scopus Google Scholar). We show a time-dependent increase in the diffusion time and particle size of poly(Q)-green fluorescent protein (GFP) fusion proteins expressed in cultured cells by FCS, oligomer we show that the poly(Q)-binding peptide QBP1 Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar) poly(Q)-GFP oligomer formation, whereas Congo red only inhibits the growth of oligomers, but not their initial formation, suggesting that FCS is capable of identifying poly(Q) oligomer inhibitors. We therefore conclude that FCS is a useful technique to monitor the oligomerization of disease-causing proteins in cells as well as inhibition of oligomerization in the conformational neurodegenerative diseases. Cell and cells and in with in a at with for various poly(Q) poly(Q) with with fluorescent protein Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, Y. T. N. Y. A. T. 2004; PubMed Scopus Google Scholar), as a to the To the of the poly(Q)-binding peptide QBP1 Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar) on poly(Q) protein for a of QBP1 with a of QBP1 with used as a with poly(Q)-GFP To the of Congo a poly(Q) aggregate on poly(Q) protein cells with poly(Q)-GFP with Congo at and a fluorescence a The of cells with inclusion bodies by the of cells with inclusion bodies by the of fluorescent cells. least cells in each and at least are expressed as the cells and in and by The inclusion bodies by at for The resulting which to inclusion bodies a fluorescence to The soluble of the each the of proteins into a and and a fluorescence and against FCS and cells poly(Q)-GFP with QBP1 at and with and Cell and at for to insoluble poly(Q)-GFP inclusion The resulting inclusion bodies to FCS FCS the with a Y. R. K. S. Kinjo M. 2005; 6: PubMed Scopus Google Scholar). Cell on at the of a a and the at FCS for at The by The of the the the the to the as the fluorescence per the of fluorescent in the with the and the diffusion time of the and the of the The diffusion time to the time for diffusion of fluorescent the which the size of the The counts per particle is by the fluorescence by the and the of the fluorescent molecules per particle We employed a a of molecules in the for and their well with a whereas for and and cells poly(Q)-GFP poly(Q)-GFP with QBP1 and by by and at with a at a by with a at a for at The and the to of the in by explore the dynamics of poly(Q) proteins in cells, we expressed poly(Q)-GFP fusion proteins with various in cells, and analyzed by conventional We that and proteins, which are within the of poly(Q) inclusion bodies in cells at whereas and proteins show a diffuse the cells and not The poly(Q)-GFP protein inclusions formed in a and poly(Q) which is with Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). inclusions in and cells the of to that formation of poly(Q) inclusions in cells is not by the fusion of to the poly(Q) We the of QBP1, a peptide that we to the poly(Q) against poly(Q) inclusion formation, and of poly(Q) inclusion formation by of QBP1 with poly(Q)-GFP as Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar) Although is that soluble oligomers are more toxic than mature amyloid and that the inclusion is cytoprotective in the poly(Q) diseases C.A. Poirier M.A. Nat. Rev. Mol. Cell Biol. 2005; 6: 891-898Crossref PubMed Scopus (515) Google Scholar, M. Mitra S. Schweitzer E.S. Segal M.R. Finkbeiner S. Nature. 2004; 431: 805-810Crossref PubMed Scopus (1627) Google Scholar, R. Science. 2003; PubMed Scopus Google Scholar), there has been little evidence of oligomer formation of the poly(Q) protein in vivo so To intracellular of the soluble poly(Q) proteins that are formation of insoluble and inclusion bodies, we of and fusion proteins in cells. poly(Q) proteins with each and in such that the can its energy to resulting in the molecule R. Trends Cell Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). in poly(Q)-GFP cells, and proteins into inclusion bodies in cells, whereas and proteins remained and not To the of the soluble and proteins, cells and at to insoluble and the soluble of the inclusions to of at that a with a at whereas a with a at we that the cells and a increase in the with a at at we a in the with a at although the of proteins used for the the as that of that soluble and We not and proteins in the soluble not that this and is the evidence for assembly of the soluble poly(Q) protein in cultured cells. In has been to monitor inclusion formation of poly(Q) proteins in S. K. Nat. Cell. Biol. 2002; PubMed Scopus Google Scholar, J. J. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). However, these only of the poly(Q) proteins into insoluble inclusion bodies, and not the molecular of the soluble poly(Q) inclusion formation is to be a cytoprotective response (6Arrasate M. Mitra S. Schweitzer E.S. Segal M.R. Finkbeiner S. Nature. 2004; 431: 805-810Crossref PubMed Scopus (1627) Google Scholar, R.R. Trends Cell Biol. 2000; 10: 524-530Abstract Full Text Full Text PDF PubMed Scopus (1614) Google Scholar), molecular of the soluble poly(Q) proteins in vivo is for of the poly(Q) proteins and its in by we demonstrated molecular of poly(Q) proteins in the soluble FRET, not such as the size of the are In addition, the of not with the of on the fluorescent probes J. A. Nat. Rev. Mol. Cell Biol. 2001; 2: PubMed Scopus Google Scholar). to and the and to explore intracellular oligomer formation of the soluble poly(Q) protein in cells, we employed FCS which is a highly sensitive technique for investigating the dynamics of fluorescent molecules in solution at single molecule (12Eigen M. Rigler R. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 5740-5747Crossref PubMed Scopus (910) Google Scholar, 13Elson E.L. Traffic. 2001; 2: 789-796Crossref PubMed Scopus (105) Google Scholar) Several dynamic properties of the fluorophore, such as the number, diffusion time, and size of the oligomerizing molecules can be analyzed by FCS (14Terada S. Kinjo M. Hirokawa N. Cell. 2000; 103: 141-155Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar, 15Jankevics H. Prummer M. Izewska P. Pick H. Leufgen K. Vogel H. Biochemistry. 2005; 44: 11676-11683Crossref PubMed Scopus (33) Google Scholar, 16Hirose M. Tohda H. Giga-Hama Y. Tsushima R. Zako T. Iizuka R. Pack C. Kinjo M. Ishii N. Yohda M. J. Biol. Chem. 2005; 280: Full Text Full Text PDF PubMed Scopus Google Scholar). cells poly(Q)-GFP at and to and the soluble of the inclusions to FCS of and which the of molecules with various diffusion are in and B. The of and with each at least suggesting that the of and molecules remained the and not However, we that the of and at the with of the poly(Q) The of the of the of and in a time-dependent and not that the of and decreased and the size of the and as with and formation of oligomeric We analyzed time-dependent of the of which is the fluorescence of the fluorescent and therefore the of poly(Q)-GFP per the of and at least suggesting that and molecules remained as a the However, importantly, we that the of and increase in a and poly(Q) that these poly(Q)-GFP molecules into oligomers the evidence for soluble oligomer formation of poly(Q) proteins in cultured cells, in which the soluble poly(Q) proteins are and not as inclusion The of at than that of at that oligomers at of on the is fluorescence of the fluorescent and the in cells at are to be a of and oligomers of various the oligomers at this time are to be than the To oligomer formation of poly(Q)-GFP proteins by we of poly(Q)-GFP proteins to we oligomeric as a The soluble of cells poly(Q)-GFP by by with We to poly(Q)-GFP in and of and proteins at the to their assembly into oligomers/aggregates we in to the in the of and cells red a not in the to which as in the by FCS. oligomers not not by FCS has in these oligomers in solution. of by a on the diffusion of poly(Q)-GFP proteins obtained by FCS, which the size of the poly(Q)-GFP and a of which with a the of and well with a suggesting that at least of fluorescent with in the and We therefore employed a to the diffusion of and a with a fast diffusion component and a slow diffusion component with fast diffusion time and slow diffusion time we that the diffusion of the fast component of and in a time-dependent suggesting that the of and molecules decreased by assembly into oligomers The of and that these molecules remained as a the The of at and and which are than that at The diffusion time is to the of the molecular the of the molecular on its diffusion is we can the size of oligomers at and to be and than that at the the size of oligomers at is to be the of to the fast diffusion component is to oligomeric oligomers are to be formed the the of aggregate formation, which is a inclusion formation, inclusion bodies are believed to be formed for misfolded aggregated proteins (7Kopito R.R. Trends Cell Biol. 2000; 10: 524-530Abstract Full Text Full Text PDF PubMed Scopus (1614) Google Scholar). We the diffusion of the slow component of and which in the soluble only poly(Q) inclusions in cells, The in and and than the at We can the size of the as the slow diffusion component to be than the and these are therefore to be large soluble the of FCS to oligomers, and large formed in cells at We the of the slow diffusion component to which the of large soluble to fluorescent We that the of of and in a time-dependent the of aggregate formation in cells The of increase in the of than that of that large than We a increase in the of of as as that the increase in the of is the for of poly(Q) protein by FCS. QBP1 in a of we the poly(Q)-binding peptide QBP1, and that QBP1 inhibits poly(Q) protein aggregation in and poly(Q) inclusion formation and in as well as in Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, Y. N. K. H. J. M. T. Mol. 2003; PubMed Scopus Google Scholar, Y. N. T. Mol. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). However, QBP1 inhibits poly(Q) oligomer formation in vivo has not been so To this we FCS of poly(Q)-GFP with QBP1 in cells. of with QBP1 the peptide at and are in of QBP1 with the of the at and suggesting that the in the of by We that the time-dependent increase in the of by the of QBP1, suggesting that QBP1 inhibits oligomerization of the poly(Q) protein these by the in the diffusion of the fast component We that of QBP1 the increase in the of that QBP1 inhibits formation of oligomers of the poly(Q) protein of the increase in the of by QBP1 only at and not at suggesting that QBP1 as of aggregation at such as oligomer is with recent that QBP1 inhibits the conformational of the poly(Q) protein which aggregate formation Y. T. N. K. Y. Y. H. T. Nat. Mol. Biol. 2007; PubMed Scopus Google Scholar). In addition, we that QBP1 cannot the poly(Q) in vitro H. Y. T. 2001; PubMed Scopus Google Scholar), that QBP1 and oligomers of the poly(Q) of the of the slow diffusion component that the time-dependent increase in the of by of QBP1, inhibition of large aggregate formation of the poly(Q) protein We a of the increase in the of as as suggesting that the is the sensitive for of the of of QBP1 on poly(Q) not to on the of as by We that the of QBP1 on inhibition of poly(Q) oligomerization for than for the poly(Q) stretch has a to with Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). We therefore conclude that FCS is a useful technique to the of poly(Q) aggregate in cells. Congo the of but the of the of FCS for aggregate for their on oligomer formation of the poly(Q) we the of Congo a known poly(Q) aggregate on poly(Q) oligomerization in cells. We cells with Congo and of poly(Q) inclusion formation as A. R. N. H. Proc. Natl. Acad. Sci. U. S. A. 2000; PubMed Scopus Google Scholar) FCS that Congo red the increase in the of suggesting that Congo red inhibits oligomerization of the poly(Q) protein However, we not of the increase in the of that Congo red not formation of oligomers of the poly(Q) protein is with a in vitro showing that Congo red the assembly of into mature but not the initial formation of M.A. H. J. S. M. C.A. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar), which is in with QBP1 We not of the increase in the of but of the increase in the CPP, that Congo red only inhibits the growth of poly(Q) oligomers/aggregates these that Congo red not the initial oligomer formation, but poly(Q) protein and the growth of poly(Q) oligomers/aggregates into aggregates, resulting in inhibition of aggregation of the poly(Q) We therefore conclude that FCS is capable of poly(Q) aggregate for their to the initial formation of oligomers the growth of of the of the to of the of QBP1 and Congo red on oligomerization of the poly(Q) protein the in their on the of the poly(Q) In we demonstrated that QBP1 the conformational of the poly(Q) protein Y. T. N. K. Y. Y. H. T. Nat. Mol. Biol. 2007; PubMed Scopus Google Scholar), whereas Congo red has been to the growth of poly(Q) protein oligomers/aggregates that are formed the conformational M.A. H. J. S. M. C.A. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). we the of of the of the poly(Q) stretch on oligomer formation, by into the poly(Q) We demonstrated that the of the poly(Q) stretch and aggregation and in Y. T. N. Y. A. T. 2004; PubMed Scopus Google Scholar). We expressed proteins with various in cells and FCS We that which has in the poly(Q) stretch a as with which has poly(Q) stretch which has a more in the which is a to suggesting that into the poly(Q) stretch oligomer formation in correlation with the of We not a with these the of well with a as we conclude that the of the poly(Q) stretch oligomer formation in cells. In this study, we and poly(Q) oligomer formation of poly(Q)-GFP proteins in Although FCS is for investigating molecules in cells, the of fluorescent probes with such as and the are known to with diffusion of fluorescent probes 2004; PubMed Scopus (33) Google Scholar). of the with in diffusion of fluorescent we to oligomer formation of poly(Q)-GFP proteins in cells, misfolded poly(Q) proteins are by (7Kopito R.R. Trends Cell Biol. 2000; 10: 524-530Abstract Full Text Full Text PDF PubMed Scopus (1614) Google Scholar), and not by is that poly(Q)-GFP proteins with various proteins such as molecular proteins, proteins, the diffusion of poly(Q)-GFP proteins Y. J. Neurosci. PubMed Google Scholar, Y. J. PubMed Scopus Google Scholar). only the diffusion time but not the fluorescence in the FCS and for the the size of poly(Q)-GFP oligomers the for at and that the for at of misfolded proteins into β-sheet-rich amyloid the of the proteins, has been as a common the conformational neurodegenerative diseases such as Alzheimer disease, Parkinson disease, and the poly(Q) diseases (1Taylor J.P. Hardy J. Fischbeck K.H. Science. 2002; 296: 1991-1995Crossref PubMed Scopus (1023) Google Scholar, 2Ross C.A. Poirier M.A. Nat. Rev. Mol. Cell Biol. 2005; 6: 891-898Crossref PubMed Scopus (515) Google Scholar, 3Carrell R.W. Lomas D.A. Lancet. 1997; 350: 134-138Abstract Full Text Full Text PDF PubMed Scopus (820) Google Scholar). The of amyloid as well as poly(Q) proteins formed in vitro to cause in in the J. Neurosci. PubMed Google Scholar, R. Mol. 2002; PubMed Google Scholar). soluble oligomers of Aβ, rather than mature amyloid are to in the pathogenesis of Alzheimer disease (8Haass C. Selkoe D.J. Nat. Rev. Mol. Cell Biol. 2007; 8: 101-112Crossref PubMed Scopus (3917) Google Scholar, 9Caughey B. Lansbury P.T. Annu. Rev. Neurosci. 2003; 26: 267-298Crossref PubMed Scopus (1458) Google Scholar, 10Stefani M. Dobson C.M. J. Mol. Med. 2003; 81: 678-699Crossref PubMed Scopus (1356) Google Scholar, 11Klein W.L. Stine Jr., W.B. Teplow D.B. Neurobiol. Aging. 2004; 25: 569-580Crossref PubMed Scopus (425) Google Scholar). The oligomers formed in to as to be toxic to in brain C. R. M. B. P. C. W.L. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). of oligomers has been to in the suggesting of oligomers in vivo R. Selkoe D.J. Nature. 2002; PubMed Scopus Google Scholar). oligomers not only of various amyloidogenic proteins but of proteins have been to cause suggesting intrinsic of the of their R. Science. 2003; PubMed Scopus Google Scholar, M. J. N. Dobson C.M. M. Nature. 2002; PubMed Scopus Google Scholar). of poly(Q) protein oligomers in vitro has been by microscopy M.A. H. J. S. M. C.A. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, H. M. Nat. Mol. Biol. 2004; PubMed Scopus Google Scholar). In this study, we demonstrated soluble oligomer formation of the poly(Q) protein in cultured cells for the time by FCS, which is implicated in the disease pathogenesis (6Arrasate M. Mitra S. Schweitzer E.S. Segal M.R. Finkbeiner S. Nature. 2004; 431: 805-810Crossref PubMed Scopus (1627) Google Scholar, P. R. C. N. N. H. K. M. Mol. Cell. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). has been believed that poly(Q) protein oligomers/aggregates formed the aggregation cause molecules that poly(Q) aggregation have been so to the poly(Q) stretch Y. T. H. D.J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, Y. N. K. H. J. M. T. Mol. 2003; PubMed Scopus Google Scholar, A. N. Nat. 2002; PubMed Scopus Google Scholar), against the poly(Q) proteins A. P. A. Proc. Natl. Acad. Sci. U. S. A. 2001; PubMed Scopus Google Scholar, Y. J.P. M. H. A. S. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar), molecular the misfolded proteins Y. J. Neurosci. PubMed Google Scholar, M.A. B. D.B. Orr H.T. H.Y. Nat. PubMed Scopus Google Scholar, H.Y. Y. Nat. 23: PubMed Scopus Google Scholar), and poly(Q) aggregation A. R. N. H. Proc. Natl. Acad. Sci. U. S. A. 2000; PubMed Scopus Google Scholar, S. A. S. R. N. S. C. H. H. Proc. Natl. Acad. Sci. U. S. A. 2002; PubMed Scopus Google Scholar, C. J. Nature. 2003; PubMed Scopus Google Scholar, M. Y. S. T. H. M. M. N. T. T. Nat. Med. 2004; 10: PubMed Scopus Google Scholar). However, of these have been to poly(Q) oligomer formation in cells for QBP1, as in this a has been to large aggregate formation of the poly(Q) protein by FCS, but not oligomer formation A. H. Pack S. Y. H. Kinjo M. K. Nat. Cell Biol. 8: PubMed Scopus Google Scholar). In this study, we demonstrated that QBP1 inhibits oligomer formation of the soluble poly(Q) protein in cultured cells by FCS, which to in vivo Y. N. K. H. J. M. T. Mol. 2003; PubMed Scopus Google Scholar, Y. N. T. Mol. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). We that Congo red only inhibits the growth of but not the initial oligomer formation of the poly(Q) The of Congo red on have remained of the of its to poly(Q) oligomer formation C. J. Nature. 2003; PubMed Scopus Google Scholar, J. Neurobiol. 2007; 25: PubMed Scopus Google Scholar). soluble oligomers are to be the oligomer formation of the soluble poly(Q) proteins in cells by FCS is for for the poly(Q) diseases. FCS can be for for of poly(Q) rather than as for the poly(Q) diseases. In we the FCS technique to poly(Q) oligomer formation in cells. We a time-dependent increase in the diffusion time and particle size of the poly(Q) oligomer formation at in cells. We large soluble with a diffusion time insoluble poly(Q) inclusions that FCS can poly(Q) protein and in cells. We demonstrated that QBP1 inhibits poly(Q) oligomer formation, whereas Congo red only inhibits the growth of oligomers, but not the initial formation of the poly(Q) oligomers, suggesting that FCS is useful for identifying poly(Q) oligomer inhibitors. We show that of the of the poly(Q) stretch by oligomer We therefore conclude that FCS is a useful technique to monitor the oligomerization of poly(Q) protein in cells as well as inhibition of oligomerization in the poly(Q) diseases, and is to the conformational neurodegenerative diseases. We J. R. and J. for with

References

35